Guohong Li
Wuhan University

Zhiguo Zhang
Columbia University Irving Medical Center 

Jessica Tyler
Weill Cornell Medicine 

Wei-Guo Zhu
Shenzhen University

Haiyun Gan
Shenzhen Institutes of Advanced Technology, CAS

We cordially invite you to participate in the third symposium on “The interplay of epigenetic regulation and genome integrity” to be held in Shenzhen, China on December 6th-10th, 2026 co-sponsored by the Biophysics Society of China (BSC) and the American Society for Biochemistry and Molecular Biology (ASBMB). The meeting will start at 7:00 pm on December 6th and will end after lunch on Thursday, December 10th. There will be seven platform sessions devoted to oral presentations and two poster sessions. In addition to presentations from two keynote speakers and 30 invited speakers, 14 short talks will be chosen from the abstracts submitted for oral presentation. 

We look forward to seeing you at the Symposium in Shenzhen, China. 

• Epigenetic regulation of genome replication
• Interplays between chromatin and epigenetic regulation and DNA repair
• Chromatin-based epigenetic inheritance
• The role of epigenetic alterations in cancer

• Mirit Aladjem, NCI/NIH, USA
• Haico van Attikum, Leiden University, Netherlands
• Haiyun Gan, Shenzhen Institutes of Advanced Technology, CAS, China
• Shiv Grewal, NCI/NIH, USA
• Jiazhi Hu, Peking University, China
• Qing Li, Peking University, China
• Guohong Li, Wuhan University, China
• David McAlpine, Duke University, USA
• Feilong Meng, Shanghai Institute of Biochemistry and Cell Biology, CAS, China
• Kyle Miller, Emory University, USA
• Danesh Moazed, Harvard University/HHMI, USA
• Andre Nussenzweig, NCI/NIH, USA
• Yang Shi, University of Oxford, UK
• Evi Soutoglou, University of Sussex, UK
• Aaron Straight, Stanford University, USA
• Jessica Tyler, Weill Cornell Medicine, USA
• Ruiming Xu, Institute of Biophysics, CAS, China
• Guoliang Xu, Fudan University, China
• Wei Yang, NIH, USA
• Yuanliang Zhai, Hong Kong University of Science and Technology, China
• Xiaodong Zhang, Imperial College London, UK
• Zhiguo Zhang, Columbia University Irving Medical Center, USA
• Bing Zhu, Institute of Biophysics, CAS, China
• Wei-Guo Zhu, Shenzhen University, China
• Lee Zou, Duke University, USA
• Jianjun Chen, Beckman Research Institute of City of Hope，USA

• Laura Baranello, Karolinska Institute, Sweden
• Irene Chiolo, University of Southern Carolina, USA
• Michael Keogh, Chief Scientific Officer of EpiCypher, USA
• Alejandro Vaquero, Josep Carreras Leukaemia Research Institute，Spain
• Xuefeng Chen, Children's Hospital of Chongqing Medical University, Chongqing, China
• Lei Shi, Tianjin Medical University, China
• Jian Yuan, Tongji University, China
• Qian Zhu, Shenzhen University, China
• Xingzhi Xu, Shenzhen University, China
• Chuanhe Yu, University of Minnesota, USA
• Haizhen Long, Shenzhen Bay Laboraotry，China
• Xiaobing Shi, cancer epigenetics, Van Andel，USA